´ëÇÑÃé´ãµµÇÐȸ [¿Â¶óÀÎ] Pancreato-Biliary Summer School 2022 (PB-SS) : 2022-06-26±³À°ÀÏÀÚ : 2022-06-26
±³À°Àå¼Ò : (¿Â¶óÀÎ) ±¤È¹® ½Å¶ó½ºÅ×ÀÌ ¹ÌÆ÷ë
±³À°ÁÖÁ¦ :
[¿Â¶óÀÎ] Pancreato-Biliary Summer School 2022 (PB-SS)ÁÖÃÖ±â°ü : ´ëÇÑÃé´ãµµÇÐȸ
´ã´çÀÚ : ¼ÛÀç¼ø
¿¬¶ôó : 02-2285-5145
À̸ÞÀÏ :
kpba@kams.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 5Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 5 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 20,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-26 ¹ÌÆ÷ë1 09:10~09:30 EUS images of normal anatomy of the pancreas and biliary tree ÇѼº¿ë(ºÎ»êÀÇ´ë)
±³À°½Ã°£ 06-26 ¹ÌÆ÷ë1 09:30~09:50 EUS-guided fine needle aspiration/biopsy ±è±¤¹Î(¼º±Õ°üÀÇ´ë â¿ø)
±³À°½Ã°£ 06-26 ¹ÌÆ÷ë1 09:50~10:10 EUS-guided pseudocyst/WON drainage ¿Àµ¿¿í(¿ï»êÀÇ´ë)
±³À°½Ã°£ 06-26 ¹ÌÆ÷ë1 10:10~10:30 EUS-related complications ¾ç¹ÎÀç(¾ÆÁÖÀÇ´ë)
ÈÞ½Ä 06-26 ¹ÌÆ÷ë1 10:30~10:40 Coffee Break ()
±³À°½Ã°£ 06-26 ¹ÌÆ÷ë1 10:40~11:00 Pre-procedure quality indicators ÀüÇü±¸(¿ø±¤ÀÇ´ë)
±³À°½Ã°£ 06-26 ¹ÌÆ÷ë1 11:00~11:20 Intra-procedure quality indicators ÀÌÀ±¼®(ÀÎÁ¦ÀÇ´ë)
±³À°½Ã°£ 06-26 ¹ÌÆ÷ë1 11:20~11:40 Post-procedure quality indicators ¹Úâȯ(Àü³²ÀÇ´ë)
ÈÞ½Ä 06-26 ¹ÌÆ÷ë1 11:40~12:40 Lunch ()
±³À°½Ã°£ 06-26 ¹ÌÆ÷ë1 12:40~13:00 Neoadjuvant and adjuvant therapy for resectable or borderline resectable pancreatic cancer ÀÌ»óÈÆ(°Ç±¹ÀÇ´ë)
±³À°½Ã°£ 06-26 ¹ÌÆ÷ë1 13:00~13:20 Standard chemotherapy for unresectable pancreatic cancer À̵¿¿í(°æºÏÀÇ´ë)
±³À°½Ã°£ 06-26 ¹ÌÆ÷ë1 13:20~13:40 Novel agents and combination therapy for unresectable pancreatic cancer ÀÌÁ¾Âù(¼¿ïÀÇ´ë)
±³À°½Ã°£ 06-26 ¹ÌÆ÷ë1 13:40~14:00 Management for chemotherapy-induced toxicity in pancreatic caner ±èÁÖ¼º(µ¿±¹ÀÇ´ë)
ÈÞ½Ä 06-26 ¹ÌÆ÷ë1 14:00~14:10 Coffee Break ()
±³À°½Ã°£ 06-26 ¹ÌÆ÷ë1 14:10~14:30 Diagnosis and risk stratification Á¶ÁßÇö(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 06-26 ¹ÌÆ÷ë1 14:30~14:50 Evaluation of recurrent or idiopathic pancreatitis ÃÖÁ¤¿Ï(°í·ÁÀÇ´ë)
±³À°½Ã°£ 06-26 ¹ÌÆ÷ë1 14:50~15:10 Medical management: intravenous fluid, nutrition, and antimicrobial therapy ±èÀÇÁÖ(°¡ÃµÀÇ´ë)
±³À°½Ã°£ 06-26 ¹ÌÆ÷ë1 15:10~15:30 Optimal management for local complications ÃÖ¿µÈÆ(°¡Å縯ÀÇ´ë)
±âŸ 06-26 ¹ÌÆ÷ë1 15:30~15:35 Closing Remarks ()